Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Multiple Sclerosis

MS Patients Rarely Perfectly Adhere to Medication Regimen Concludes Massachusetts General Hospital-led Virtual Clinical Trial

A recent study sponsored by Massachusetts General Hospital in collaboration with the National Multiple Sclerosis Society and Pillsy Inc. was […]

MS Patients Rarely Perfectly Adhere to Medication Regimen Concludes Massachusetts General Hospital-led Virtual Clinical Trial
4 days ago
Share

aHSCT for MS Patients—The Italian Study & the BEAT-MS Trial

A recent study led in Italy was organized to investigate the question whether autologous hematopoietic stem cell transplantation (aHSCT) can […]

aHSCT for MS Patients—The Italian Study & the BEAT-MS Trial
2 weeks ago
Share

Study Suggests Majority of Rituximab Use Is Off Label

The term “off-label” is described by the FDA as an unapproved use of an approved drug. Recently, a study conducted […]

Study Suggests Majority of Rituximab Use Is Off Label
8 months ago
Share

Duke Participates in the BEAT-MS Clinical Trial Comparing Stem Cell Transplantation to Immunotherapy

Duke University, through the Immune Tolerance Network, is offering a multicenter, Phase III interventional clinical trial examining the efficacy of […]

Duke Participates in the BEAT-MS Clinical Trial Comparing Stem Cell Transplantation to Immunotherapy
1 year ago
Share

Monash University Investigators One Step Closer to Novel Treatment for MS

Monash University investigators are in pursuit for a new treatment for multiple sclerosis (MS) that they believe may actually reverse […]

Monash University Investigators One Step Closer to Novel Treatment for MS
1 year ago
Share

Trinity College Dublin New Discovery Offers Hope for Improved MS Therapies in The Future

Researchers from Trinity College Dublin have made an important discovery that may lead to more effective multiple sclerosis (MS) treatments […]

Trinity College Dublin New Discovery Offers Hope for Improved MS Therapies in The Future
1 year ago
Share

GeNeuro Secures €17.5 million in the Nick of Time for MS Clinical Trial

GeNeuro, a European biopharmaceutical company developing new treatments, focused on stopping causal factors driving the progression of neurodegenerative and autoimmune […]

GeNeuro Secures €17.5 million in the Nick of Time for MS Clinical Trial
1 year ago
Share

Short Sellers Pursue Principia Biopharma Arguing the Addressing Autoimmune Disease with BTK Inhibitors Flawed Strategy

Boutique short-seller Kerrisdale Capital Management (KCM), a private investment manager, recently published a report explaining why they have taken a […]

Short Sellers Pursue Principia Biopharma Arguing the Addressing Autoimmune Disease with BTK Inhibitors Flawed Strategy
1 year ago
Share

Case Western Reserve University Researchers Developed Myeliviz, Heads to Phase I Clinical Trial for MS

Case Western Reserve University researchers have developed a drug known as Myeliviz that could make it easier for doctors to […]

Case Western Reserve University Researchers Developed Myeliviz, Heads to Phase I Clinical Trial for MS
1 year ago
Share

OMRF Investigates Dimethyl Fumarate on Use for Multiple Sclerosis

Oklahoma Medical Research Foundation (OMRF) researchers are investigating how an FDA—approved multiple sclerosis drug affects vision loss. It so happens […]

OMRF Investigates Dimethyl Fumarate on Use for Multiple Sclerosis
1 year ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.